Pharmacokinetics Guides
Comprehensive PK parameter guides for 181+ drugs. Each guide includes key pharmacokinetic data, dosing information, and an interactive simulator.
5-Fluorouracil Pharmacokinetics Guide
Cancer chemotherapy
Antimetabolite
Read guide →ADC Effector Function Model Pharmacokinetics Guide
Solid Tumors
ADC
Read guide →ADCs Pharmacokinetics Guide
HER2-positive breast cancer, NSCLC, gastric/GEJ cancer
Antibody-Drug Conjugate (ADC)
Read guide →BTK Degrader Pharmacokinetics Guide
B-cell Malignancies
PROTAC
Read guide →BTK Targeted Degrader Pharmacokinetics Guide
B-cell Malignancies
PROTAC
Read guide →Cisplatin Pharmacokinetics Guide
Cancer chemotherapy
Platinum
Read guide →Darzalex (Daratumumab) Pharmacokinetics Guide
Multiple myeloma
mAb
Read guide →Dato Pharmacokinetics Guide
TROP2-positive metastatic breast cancer
Antibody-Drug Conjugate (ADC)
Read guide →Datroway Pharmacokinetics Guide
Locally advanced or metastatic non-squamous NSCLC (TROPION-Lung08), HR+/HER2-low/negative metastatic breast cancer (TROPION-Breast01), and triple-negative breast cancer; TROP2-directed ADC with DXd payload
Antibody-Drug Conjugate (ADC)
Read guide →Doxorubicin Pharmacokinetics Guide
Cancer chemotherapy
Anthracycline
Read guide →Enhertu Pharmacokinetics Guide
HER2-positive breast cancer, gastric/gastroesophageal adenocarcinoma, NSCLC
Antibody-Drug Conjugate (ADC)
Read guide →Ibrance (Palbociclib) Pharmacokinetics Guide
HR+/HER2- metastatic breast cancer
Small Molecule
Read guide →Imatinib Pharmacokinetics Guide
CML / GIST
Small Molecule
Read guide →Imbruvica (Ibrutinib) Pharmacokinetics Guide
Chronic lymphocytic leukemia
Small Molecule
Read guide →Imfinzi (Durvalumab) Pharmacokinetics Guide
Non-small cell lung cancer
mAb
Read guide →Infigratinib Pharmacokinetics Guide
Cholangiocarcinoma
Small Molecule
Read guide →Keytruda (Pembrolizumab) Pharmacokinetics Guide
Melanoma and non-small cell lung cancer
mAb
Read guide →Keytruda Pharmacokinetics Guide
Cancer immunotherapy
PD-1 inhibitor
Read guide →Lynparza (Olaparib) Pharmacokinetics Guide
BRCA-mutated ovarian cancer
Small Molecule
Read guide →Methotrexate High-Dose Pharmacokinetics Guide
Cancer/RA
Antimetabolite
Read guide →Oncology Dose Selection Tool Pharmacokinetics Guide
Solid Tumors
Small Molecule
Read guide →Opdivo (Nivolumab) Pharmacokinetics Guide
Melanoma and non-small cell lung cancer
mAb
Read guide →PBPK-PD Topo1-Based ADC Pharmacokinetics Guide
Solid tumors (breast, lung, gastric, colorectal cancer)
Antibody-Drug Conjugate (ADC)
Read guide →PBPK-PD Topo1-Based ADC Pharmacokinetics Guide
Solid tumors (HER2-positive and Trop-2-positive cancers)
Antibody-Drug Conjugate
Read guide →PBPK-PD Topo1-Based ADC Pharmacokinetics Guide
Solid tumors (breast, lung, gastric, colorectal cancer)
Antibody-Drug Conjugate (ADC)
Read guide →PBPK-PD of ADCs Pharmacokinetics Guide
Antibody-Drug Conjugate (ADC)
Read guide →Paclitaxel Pharmacokinetics Guide
Cancer chemotherapy
Taxane
Read guide →Perjeta (Pertuzumab) Pharmacokinetics Guide
HER2-positive breast cancer
mAb
Read guide →Pomalyst (Pomalidomide) Pharmacokinetics Guide
Multiple myeloma
Small Molecule
Read guide →PopPK of Docetaxel Pharmacokinetics Guide
Taxane (Microtubule Stabilizer)
Read guide →Revlimid (Lenalidomide) Pharmacokinetics Guide
Multiple myeloma
Small Molecule
Read guide →Ruc Pharmacokinetics Guide
BRCA-mutant and HRD+ breast cancer
PARP inhibitor
Read guide →T-cell Engager Pharmacokinetics Guide
Hematologic Malignancies
mAb
Read guide →TMDD Model Pharmacokinetics Guide
HER2-positive Breast Cancer
Monoclonal Antibody (Anti-HER2)
Read guide →Tagrisso (Osimertinib) Pharmacokinetics Guide
EGFR-mutated non-small cell lung cancer
Small Molecule
Read guide →Tecentriq (Atezolizumab) Pharmacokinetics Guide
Non-small cell lung cancer
mAb
Read guide →Trastuzumab (Herceptin) PBPK-TMDD Pharmacokinetics Guide
HER2-positive breast cancer
Anti-HER2 Monoclonal Antibody
Read guide →Trastuzumab Pharmacokinetics Guide
HER2+ Breast Cancer
mAb
Read guide →Trastuzumab Pharmacokinetics Guide
HER2+ Breast Cancer
mAb
Read guide →Trastuzumab Pharmacokinetics Guide
Monoclonal Antibody
Read guide →Trodelvy Pharmacokinetics Guide
Unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC), HR+/HER2-negative metastatic breast cancer after endocrine and CDK4/6 inhibitor therapy, and locally advanced or metastatic urothelial cancer; TROP2-directed ADC with SN-38 payload
Antibody-Drug Conjugate (ADC)
Read guide →Tumor Exposure Analysis Model Pharmacokinetics Guide
Solid Tumors
mAb
Read guide →Verzenio (Abemaciclib) Pharmacokinetics Guide
HR+/HER2- metastatic breast cancer
Small Molecule
Read guide →Xtandi (Enzalutamide) Pharmacokinetics Guide
Metastatic castration-resistant prostate cancer
Small Molecule
Read guide →capecitabine Pharmacokinetics Guide
Fluoropyrimidine / Oral Prodrug
Read guide →lenvatinib_Gupta_26879594 Pharmacokinetics Guide
Advanced renal cell carcinoma, hepatocellular carcinoma, differentiated thyroid cancer
Multikinase Inhibitor (TKI)
Read guide →rucaparib ok model Pharmacokinetics Guide
Ovarian cancer, metastatic castration-resistant prostate cancer (mCRPC)
PARP Inhibitor
Read guide →rucaparib Pharmacokinetics Guide
BRCA-mutated advanced ovarian, fallopian tube, or primary peritoneal cancer
PARP Inhibitor
Read guide →Build Your Own PK/PD Simulator
PKPDBuilder uses AI to transform published pharmacometric literature into interactive Shiny applications. No coding required.
Get Started Free